361 related articles for article (PubMed ID: 35328792)
1. Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions.
Doyon-Laliberté K; Aranguren M; Poudrier J; Roger M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328792
[TBL] [Abstract][Full Text] [Related]
2. Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection.
Doyon-Laliberté K; Aranguren M; Byrns M; Chagnon-Choquet J; Paniconi M; Routy JP; Tremblay C; Quintal MC; Brassard N; Kaufmann DE; Poudrier J; Roger M
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499469
[TBL] [Abstract][Full Text] [Related]
3. Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations.
Doyon-Laliberté K; Aranguren M; Chagnon-Choquet J; Batraville LA; Dagher O; Richard J; Paniconi M; Routy JP; Tremblay C; Quintal MC; Brassard N; Kaufmann DE; Finzi A; Poudrier J; Roger M
Curr Issues Mol Biol; 2023 Dec; 46(1):25-43. PubMed ID: 38275663
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals.
Aranguren M; Doyon-Laliberté K; El-Far M; Chartrand-Lefebvre C; Routy JP; Barril JG; Trottier B; Tremblay C; Durand M; Poudrier J; Roger M;
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679926
[TBL] [Abstract][Full Text] [Related]
5. Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection.
Borhis G; Trovato M; Ibrahim HM; Isnard S; Le Grand R; Bosquet N; Richard Y
Front Immunol; 2020; 11():252. PubMed ID: 32194549
[TBL] [Abstract][Full Text] [Related]
6. Fluctuations in Blood Marginal Zone B-Cell Frequencies May Reflect Migratory Patterns Associated with HIV-1 Disease Progression Status.
Gauvin J; Chagnon-Choquet J; Poudrier J; Roger M;
PLoS One; 2016; 11(5):e0155868. PubMed ID: 27203285
[TBL] [Abstract][Full Text] [Related]
7. Blood B Lymphocyte Stimulator (BLyS)/BAFF levels may reflect natural immunity to HIV in highly exposed uninfected Beninese Commercial Sex Workers.
Sabourin-Poirier C; Fourcade L; Chagnon-Choquet J; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
Sci Rep; 2016 Aug; 6():32318. PubMed ID: 27561453
[TBL] [Abstract][Full Text] [Related]
8. Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequencies of innate marginal zone like CD1c+ B-cells in the genital tract.
Fourcade L; Sabourin-Poirier C; Perraud V; Faucher MC; Chagnon-Choquet J; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
PLoS Pathog; 2019 Jun; 15(6):e1007840. PubMed ID: 31173604
[TBL] [Abstract][Full Text] [Related]
9. High expression levels of BLyS/BAFF by blood dendritic cells and granulocytes are associated with B-cell dysregulation in SIV-infected rhesus macaques.
Poudrier J; Soulas C; Chagnon-Choquet J; Burdo T; Autissier P; Oskar K; Williams KC; Roger M
PLoS One; 2015; 10(6):e0131513. PubMed ID: 26107380
[TBL] [Abstract][Full Text] [Related]
10. Natural Immunity to HIV: A Template for Vaccine Strategies.
Fourcade L; Poudrier J; Roger M
Viruses; 2018 Apr; 10(4):. PubMed ID: 29690575
[TBL] [Abstract][Full Text] [Related]
11. IL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.
Chagnon-Choquet J; Fontaine J; Poudrier J; Roger M; ;
PLoS One; 2014; 9(7):e101949. PubMed ID: 25003989
[TBL] [Abstract][Full Text] [Related]
12. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
[TBL] [Abstract][Full Text] [Related]
13. NR4A Expression by Human Marginal Zone B-Cells.
Doyon-Laliberté K; Chagnon-Choquet J; Byrns M; Aranguren M; Memmi M; Chrobak P; Stagg J; Poudrier J; Roger M
Antibodies (Basel); 2019 Oct; 8(4):. PubMed ID: 31614541
[TBL] [Abstract][Full Text] [Related]
14. Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infection.
Demberg T; Mohanram V; Musich T; Brocca-Cofano E; McKinnon KM; Venzon D; Robert-Guroff M
Virology; 2015 Oct; 484():323-333. PubMed ID: 26151223
[TBL] [Abstract][Full Text] [Related]
15. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
[TBL] [Abstract][Full Text] [Related]
16. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
Mackay F; Sierro F; Grey ST; Gordon TP
Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
[TBL] [Abstract][Full Text] [Related]
17. B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection.
Borhis G; Trovato M; Chaoul N; Ibrahim HM; Richard Y
Front Immunol; 2017; 8():1338. PubMed ID: 29163465
[TBL] [Abstract][Full Text] [Related]
18. CD19 regulates ADAM28-mediated Notch2 cleavage to control the differentiation of marginal zone precursors to MZ B cells.
Zhang Y; Zhu G; Xiao H; Liu X; Han G; Chen G; Hou C; Shen B; Li Y; Ma N; Wang R
J Cell Mol Med; 2017 Dec; 21(12):3658-3669. PubMed ID: 28707394
[TBL] [Abstract][Full Text] [Related]
19. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.
Li Z; Wang H; Xue L; Shin DM; Roopenian D; Xu W; Qi CF; Sangster MY; Orihuela CJ; Tuomanen E; Rehg JE; Cui X; Zhang Q; Morse HC; Morris SW
Blood; 2009 Nov; 114(19):4158-68. PubMed ID: 19696203
[TBL] [Abstract][Full Text] [Related]
20. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
